The Cox regression analysis revealed that several factors, including the overexpression of SUMF1, IDH status, 1p/19q codeletion, age, and histological subtype, contribute to the risk of poor OS, DSS, and cancer progression among glioma patients (Tables 2–4). The gene discussed is SUMF1; the disease is central nervous system cancer.